File S E, Wilks L J
Psychopharmacology Research Unit, UMDS Division of Pharmacology, University of London, Guy's Hospital, UK.
Psychopharmacology (Berl). 1990;100(2):237-42. doi: 10.1007/BF02244413.
Sodium phenobarbitone (20 and 70 mg/kg) had a significant anticonvulsant action against pentylenetetrazole-induced seizures, which persisted for 21 days of treatment. On drug withdrawal there was a significant decrease in seizure threshold below control level 24-48 h after the last dose of 70 mg/kg. Phenytoin (40 mg/kg) had a significant anticonvulsant action after 7 days of treatment and this persisted for 21 days of treatment. On drug withdrawal there was a significant decrease in seizure threshold 48 h after the last dose. Lorazepam (0.1 mg/kg) had a significant anticonvulsant action, but the group tested after 21 days of treatment did not differ from the controls, indicating that tolerance had developed to this effect; on drug withdrawal there was a decrease in seizure threshold from 24 to 72 h. The only drug to increase aggressive behaviour was sodium phenobarbitone (70 mg/kg); this reached significance after 14 and 21 days of treatment and occurred 8 h after drug administration; 0.5 h after drug administration phenobarbitone (70 mg/kg) abolished aggressive behaviour. After 7 days of treatment phenobarbitone (70 mg/kg) increased social behaviour 0.5 h after administration and this was still increased after 21 days of treatment. On drug withdrawal, there were no changes in aggressive behaviour, but there were significant decreases in social behaviour 24 and 48 h after phenobarbitone (70 mg/kg) withdrawal and 24, 48 and 72 h after lorazepam (0.1 mg/kg) withdrawal.
苯巴比妥钠(20和70毫克/千克)对戊四氮诱导的癫痫发作具有显著的抗惊厥作用,该作用在治疗的21天内持续存在。在停药后,在最后一剂70毫克/千克给药后24 - 48小时,癫痫发作阈值显著降至对照水平以下。苯妥英(40毫克/千克)在治疗7天后具有显著的抗惊厥作用,且该作用在治疗的21天内持续存在。在停药后,在最后一剂给药后48小时癫痫发作阈值显著降低。劳拉西泮(0.1毫克/千克)具有显著的抗惊厥作用,但在治疗21天后测试的组与对照组无差异,表明对该作用已产生耐受性;在停药后,癫痫发作阈值在24至72小时降低。唯一增加攻击行为的药物是苯巴比妥钠(70毫克/千克);在治疗14天和21天后这种情况显著出现,且在给药后8小时发生;给药后0.5小时,苯巴比妥钠(70毫克/千克)消除了攻击行为。在治疗7天后,苯巴比妥钠(70毫克/千克)在给药后0.5小时增加了社交行为,且在治疗21天后仍有增加。在停药后,攻击行为无变化,但在苯巴比妥钠(70毫克/千克)停药后24和48小时以及劳拉西泮(0.1毫克/千克)停药后24、48和72小时社交行为显著减少。